Latest & greatest articles for insomnia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on insomnia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on insomnia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for insomnia

521. Pharmacologic treatment of sleep apnea

Pharmacologic treatment of sleep apnea Pharmacologic treatment of sleep apnea Pharmacologic treatment of sleep apnea HAYES, Inc. Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation HAYES, Inc.. Pharmacologic treatment of sleep apnea. Lansdale: HAYES, Inc.. Directory Publication. 2005 Authors' objectives The goal of pharmacologic therapy for sleep apnea syndrome (...) is to restore airway competence, to reduce morbidity and excessive mortality by reversing underlying hypoxia, hypercapnia, and acidosis, and to improve the quality of life for the patient. Final publication URL The report may be purchased from: Indexing Status Subject indexing assigned by CRD MeSH Sleep Apnea Syndromes /drug therapy Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence HAYES, Inc., 157 S. Broad

2005 Health Technology Assessment (HTA) Database.

522. Manifestations and management of chronic insomnia in adults

; Cognitive Therapy; Melatonin; Relaxation Therapy; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders Language Published English Country of organisation United States Address for correspondence Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639; Email: martin.erlichman@ahrq.hhs.gov AccessionNumber 32005000282 Date bibliographic record published 17/06/2005 Date abstract record published 17/06 (...) Manifestations and management of chronic insomnia in adults Manifestations and management of chronic insomnia in adults Manifestations and management of chronic insomnia in adults Buscemi N, Vandermeer B, Friesen C, Bialy L, Tubman M, Ospina M, Klassen TP, Witmans M Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Buscemi N, Vandermeer B

2005 Health Technology Assessment (HTA) Database.

523. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits

Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

524. Cognitive behavioural therapy for primary insomnia: a systematic review

Cognitive behavioural therapy for primary insomnia: a systematic review Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

525. Screening for obstructive sleep apnea in stroke patients: a cost-effectiveness analysis Full Text available with Trip Pro

Screening for obstructive sleep apnea in stroke patients: a cost-effectiveness analysis Screening for obstructive sleep apnea in stroke patients: a cost-effectiveness analysis Screening for obstructive sleep apnea in stroke patients: a cost-effectiveness analysis Brown D L, Chervin R D, Hickenbottom S L, Langa K M, Morgenstern L B Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary (...) of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The study compared polysomnography (PSG), a screening strategy for detecting obstructive sleep apnoea (OSA), against no screening. Patients found positive subsequently received continuous positive airway pressure (CPAP) treatment. Type of intervention Screening and treatment. Economic study type Cost-utility analysis. Study population

2005 NHS Economic Evaluation Database.

526. Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study. (Abstract)

Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study. In July, 1999, a single dose of live-attenuated SA 14-14-2 Japanese encephalitis vaccine was given to children aged 1-15 years in the Terai region of Nepal. Cases of natural infection occurred almost immediately. Our aim was to assess the long-term protective effect of this vaccination.In 2000, this same population had a second seasonal exposure (...) unbiased estimate of the odds ratio of 0.0155, with lower and upper confidence limits of 0.0004 and 0.0986. The protective effect of vaccine after 12-15 months was 98.5% (CI 90.1-99.2%).Our study provides evidence of sustained high protection afforded by one dose of live attenuated SA 14-14-2 vaccine in Nepalese children.

2005 Lancet

527. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. (Abstract)

with untreated obstructive sleep apnoea-hypopnoea, patients treated with CPAP, and healthy men recruited from the general population.We recruited men with obstructive sleep apnoea-hypopnoea or simple snorers from a sleep clinic, and a population-based sample of healthy men, matched for age and body-mass index with the patients with untreated severe obstructive sleep apnoea-hypopnoea. The presence and severity of the disorder was determined with full polysomnography, and the apnoea-hypopnoea index (AHI (...) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. The effect of obstructive sleep apnoea-hypopnoea as a cardiovascular risk factor and the potential protective effect of its treatment with continuous positive airway pressure (CPAP) is unclear. We did an observational study to compare incidence of fatal and non-fatal cardiovascular events in simple snorers, patients

2005 Lancet

528. Oral appliances for obstructive sleep apnoea. (Abstract)

Oral appliances for obstructive sleep apnoea. Obstructive sleep apnoea-hypopnoea is a syndrome characterised by recurrent episodes of partial or complete upper airway obstruction during sleep that are usually terminated by an arousal. Nasal continuous positive airway pressure is the primary treatment for obstructive sleep apnoea-hypopnoea, but many patients are unable or unwilling to comply with this treatment. Oral appliances are an alternative treatment for sleep apnoea.The objective (...) continuous positive pressure in reducing apnoea-hypopnoea index (WMD 13 [95% CI: 7.63, 18.36], parallel studies - two trials; WMD 6.96 [4.82, 9.10] cross-over studies - six trials). However, no significant difference was observed on symptom scores. Nasal continuous positive pressure was more effective at improving minimum arterial oxygen saturation during sleep compared with oral appliance. In two small crossover studies, participants preferred oral appliance therapy to continuous positive airways

2004 Cochrane

529. Review: continuous positive airway pressure therapy improves subjective and objective sleepiness in obstructive sleep apnoea Full Text available with Trip Pro

Therapeutics Review: continuous positive airway pressure therapy improves subjective and objective sleepiness in obstructive sleep apnoea Free P John Rees , MD Statistics from Altmetric.com ( 2003 ) Arch Intern Med 163 , 565 . Patel SR, White DP, Malhotra A, et al. . Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. . ; . : . –71 . QUESTION: In patients with obstructive sleep apnoea (OSA), does continuous (...) Review: continuous positive airway pressure therapy improves subjective and objective sleepiness in obstructive sleep apnoea Review: continuous positive airway pressure therapy improves subjective and objective sleepiness in obstructive sleep apnoea | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log

2004 Evidence-Based Medicine

530. Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia (TA77)

Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia (TA77) Overview | Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia | Guidance | NICE Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia Technology appraisal guidance [TA77] Published date: 28 April 2004 Share Save Guidance on zolpidem and zopiclone for treating insomnia in adults. The recommendations

2004 National Institute for Health and Clinical Excellence - Technology Appraisals

531. Melatonin for treatment of sleep disorders

indexing assigned by CRD MeSH Jet Lag Syndrome /drug therapy; Melatonin; Sleep Initiation and Maintenance Disorders /drug therapy; Sleep Wake Disorders /drug therapy Language Published English Country of organisation United States Address for correspondence Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639; Email: martin.erlichman@ahrq.hhs.gov AccessionNumber 32004000874 Date bibliographic record (...) , although there is some evidence to suggest that melatonin is effective in treating delayed sleep phase syndrome with short-term use. - Evidence suggests that melatonin is not effective in treating most secondary sleep disorders with short-term use. - No evidence suggests that melatonin is effective in alleviating the sleep disturbance aspect of jet lag and shift-work disorder. - Evidence suggests that melatonin is safe with short-term use. Project page URL URL for DARE abstract Indexing Status Subject

2004 Health Technology Assessment (HTA) Database.

532. Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation

, the short-term trial of medication and lack of long-term follow-up undermine attempts to develop evidence-based guidelines for the use of hypnotics in this condition, or indeed for its whole management. Project page URL URL for DARE abstract INAHTA brief and checklist Indexing Status Subject indexing assigned by CRD MeSH Costs and Cost Analysis; Hypnotics and Sedatives; Sleep Initiation and Maintenance Disorders /drug therapy; Sleep Wake Disorders /drug therapy Language Published English Country (...) conclusions. We would also recommend that any such trial should include a placebo arm. It should also collect good-quality data around sleep outcomes and in particular quality of life and daytime drowsiness. We do not believe that any formal study of risk of dependency is feasible at present. Finally, the major research issue is perhaps not around the management of short-term insomnia, but around the management of long-term insomnia: considering the frequency of this symptom and its recurring course

2004 Health Technology Assessment (HTA) Database.

533. Psychological treatment for insomnia in the regulation of long-term hypnotic drug use

by primary care commissioners and practitioners when implementing National Service Framework recommendations for benzodiazepine use, and when addressing the insomnia management needs of patients with longer term sleep difficulties. Project page URL INAHTA brief and checklist Indexing Status Subject indexing assigned by CRD MeSH Cognitive Therapy; Hypnotics and Sedatives; Psychotherapy; Sleep Initiation and Maintenance Disorders Language Published English Country of organisation England Address (...) database. Citation Morgan K, Dixon S, Mathers N, Thompson J, Tomeny M. Psychological treatment for insomnia in the regulation of long-term hypnotic drug use. Health Technology Assessment 2004; 8(8): 1-80 Authors' objectives This study was designed: (1) to evaluate the clinical and cost impact of providing, in routine general practice settings, a cognitive-behaviour therapy (CBT) package for insomnia (comprising information, sleep hygiene, stimulus control, relaxation and cognitive therapy components

2004 Health Technology Assessment (HTA) Database.

534. Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia

indexing assigned by CRD MeSH Acetamides /therapeutic use; Benzodiazepines /therapeutic use; GABA Agonists /therapeutic use; Hypnotics and Sedatives /therapeutic use; Piperazines /therapeutic use; Pyridines /therapeutic use; Pyrimidines /therapeutic use; Sleep Initiation and Maintenance Disorders /drug therapy Language Published English Country of organisation England Address for correspondence MidCity Place, 71 High Holborn, London WC1V 6NA, UK Tel: +44 020 7067 5800; Fax: +44 020 7067 5801 Email (...) Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia National Institute for Clinical Excellence Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made

2004 Health Technology Assessment (HTA) Database.

535. Efficacy and co-morbidity of oral appliances in the treatment of obstructive sleep apnea-hypopnea: a systematic review

with the obstructive sleep apnoea-hypopnoea syndrome (OSAHS). Searching MEDLINE, EMBASE, CINAHL and the Cochrane CENTRAL Register were searched from inception to 2002 using the reported search terms. In addition, experts were contacted for details of unpublished or ongoing studies and reference lists of reviews and eligible studies were screened. No language restrictions were applied to the searches, but studies in Hebrew and Asian languages were excluded from the review. Studies reported as abstracts were also (...) Efficacy and co-morbidity of oral appliances in the treatment of obstructive sleep apnea-hypopnea: a systematic review Efficacy and co-morbidity of oral appliances in the treatment of obstructive sleep apnea-hypopnea: a systematic review Efficacy and co-morbidity of oral appliances in the treatment of obstructive sleep apnea-hypopnea: a systematic review Hoekema A, Stegenga B, De Bont L G CRD summary This review assessed the efficacy and safety of oral appliances (OAs) in obstructive sleep

2004 DARE.

536. Melatonin for treatment of sleep disorders

of the review. The studies were generally of a moderate-to-high quality. Effectiveness of melatonin in people with a primary sleep disorder. Melatonin decreased SOL in people with a primary sleep disorder (WMD -10.7 minutes, 95% confidence interval, CI: -17.6, -3.7), though studies were heterogeneous (I-squared 81.5%). SOL was decreased greatly in people with delayed sleep phase syndrome (WMD -38.8 minutes, 95% CI: -50.3, -27.3). SOL was decreased marginally in patients with insomnia, but the size (...) in the included studies ranged from 0.1 to 80 mg, with a mode of 5 mg. The control groups received placebo. Participants included in the review Studies were included in the review if they involved human participants suffering from a sleep disorder and this condition was explicitly mentioned in the report. Outcomes assessed in the review Studies were included in the review if at least one of the following outcomes was assessed: sleep onset latency (SOL), sleep efficiency, sleep quality, wakefulness after sleep

2004 DARE.

537. Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies

/drug effects; Sleep Wake Disorders /diagnosis /drug therapy /epidemiology; Treatment Outcome AccessionNumber 12004006589 Date bibliographic record published 31/08/2006 Date abstract record published 31/08/2006 Record Status This is a critical abstract of a systematic review that meets the criteria for inclusion on DARE. Each critical abstract contains a brief summary of the review methods, results and conclusions followed by a detailed critical assessment on the reliability of the review (...) Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies Cohen-Zion M, Ancoli-Israel S CRD summary This review assessed the effects of psychostimulants on sleep

2004 DARE.

538. Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation

A, Dickson R, Walley T. Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Human Psychopharmacology 2004;19(5):305-322. Indexing Status Subject indexing assigned by NLM MeSH Adult; Aged; Cost-Benefit Analysis; Female; Humans; Hypnotics and Sedatives /administration & Male; Middle Aged; Randomized Controlled Trials as Topic; Sleep Initiation and Maintenance Disorders /drug therapy; Treatment Outcome; dosage /adverse effects (...) with insomnia were eligible for inclusion. Outcomes of interest were: sleep onset latency, total sleep duration, number of awakenings, sleep quality, rebound insomnia (for all of the previous outcomes) and adverse events. For the extended review on dependency and withdrawals, case-control studies, case series, case reports, cohort studies, and surveys were also eligible. Included studies were conducted in a range of settings and different countries, with study durations lasting between one night and six

2004 DARE.

539. The effect of positioning on the severity of sleep apnea syndrome and its relevance In the avoidance of hypoxia in acute stroke

The effect of positioning on the severity of sleep apnea syndrome and its relevance In the avoidance of hypoxia in acute stroke The effect of positioning on the severity of sleep apnea syndrome and its relevance In the avoidance of hypoxia in acute stroke The effect of positioning on the severity of sleep apnea syndrome and its relevance In the avoidance of hypoxia in acute stroke Nightingale P CRD summary This review evaluated sleep positioning to treat sleep apnoea syndrome (SAS). The author (...) concluded that adopting a side lying or sitting position may reduce the incidence of apnoeic attacks in some SAS patients. This review had several methodological limitations in relation to the review process and quality of the included studies, therefore the reliability of the author's conclusion is unclear. Authors' objectives To evaluate the effect of sleep positioning as a treatment for sleep apnoea syndrome (SAS). The author also assessed non-intervention studies to determine the patient

2004 DARE.

540. Annual review of patients with sleep apnea/hypopnea syndrome: a pragmatic randomised trial of nurse home visit versus consultant clinic review

, Godden D J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Two methods for the annual review of patients diagnosed with obstructive sleep apnoea/hypopnoea syndrome (SAHS), who were being treated with constant positive airway (...) Annual review of patients with sleep apnea/hypopnea syndrome: a pragmatic randomised trial of nurse home visit versus consultant clinic review Annual review of patients with sleep apnea/hypopnea syndrome: a pragmatic randomised trial of nurse home visit versus consultant clinic review Annual review of patients with sleep apnea/hypopnea syndrome: a pragmatic randomised trial of nurse home visit versus consultant clinic review Palmer S, Selvaraj S, Dunn C, Osman L M, Cairns J, Franklin D, Hulks G

2004 NHS Economic Evaluation Database.